We would like to introduce the following new publication that reports plasma FGF21 levels are shown to associate with low protein intake, lower muscle mass, lower vitality, and more fatigue in hemodialysis patients.

The report has concluded that FGF21 could be a potential biomarker for
assessing protein intake and PEW in hemodialysis patients.

Post A et al. Fibroblast growth factor 21 and protein energy wasting in hemodialysis patients.
Clin Nutr. 2021 Feb 3:S0261-5614(21)00063-7.

#27997 Human FGF21 Assay Kit – IBL is used for measuring plasma FGF21 in this study.

We look forward to supporting your future research.

Please feel free to contact us if you have any questions.